MedInnovateHub reports first-half results: steady growth in Europe and Asia-Pacific

Shenzhen — MedInnovateHub today summarized unaudited results for the first six months of the fiscal year, highlighting mid-single-digit revenue growth year over year at constant currency, driven by patient monitoring refreshes and ultrasound demand in public hospital tenders.

Regional highlights

Europe benefited from MDR-aligned product transitions and service contract renewals. In Asia-Pacific, several multi-hospital awards contributed to instrument revenue, partially offset by longer installation cycles in a few markets. Gross margin held stable as supply chain conditions normalized versus the prior period.

Outlook

Management reaffirmed full-year guidance ranges issued in the spring, noting continued investment in R&D and regional customer support. A detailed filing and investor call materials are available to registered stakeholders through the company’s disclosure channels.

Note: Figures in this summary are illustrative for website demonstration and do not constitute financial advice or official filings.